RT Journal Article SR Electronic T1 Partition Model–Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison JF Journal of Nuclear Medicine JO J Nucl Med FD Society of Nuclear Medicine SP 1672 OP 1678 DO 10.2967/jnumed.116.173104 VO 57 IS 11 A1 Gnesin, Silvano A1 Canetti, Laurent A1 Adib, Salim A1 Cherbuin, Nicolas A1 Silva Monteiro, Marina A1 Bize, Pierre A1 Denys, Alban A1 Prior, John O. A1 Baechler, Sebastien A1 Boubaker, Ariane YR 2016 UL http://jnm.snmjournals.org/content/57/11/1672.abstract AB 90Y-microsphere selective internal radiation therapy (SIRT) is a valuable treatment in unresectable hepatocellular carcinoma (HCC). Partition-model predictive dosimetry relies on differential tumor-to-nontumor perfusion evaluated on pretreatment 99mTc-macroaggregated albumin (MAA) SPECT/CT. The aim of this study was to evaluate agreement between the predictive dosimetry of 99mTc-MAA SPECT/CT and posttreatment dosimetry based on 90Y time-of-flight (TOF) PET/CT. Methods: We compared the 99mTc-MAA SPECT/CT results for 27 treatment sessions (25 HCC patients, 41 tumors) with 90Y SIRT (7 glass spheres, 20 resin spheres) and the posttreatment 90Y TOF PET/CT results. Three-dimensional voxelized dose maps were computed from the 99mTc-MAA SPECT/CT and 90Y TOF PET/CT data. Mean absorbed dose () was evaluated to compute the predicted-to-actual dose ratio () in tumor volumes (TVs) and nontumor volumes (NTVs) for glass and resin spheres. The Lin concordance () was used to measure accuracy () and precision (ρ). Results: Administered activity ranged from 0.8 to 1.9 GBq for glass spheres and from 0.6 to 3.4 GBq for resin spheres, and the respective TVs ranged from 2 to 125 mL and from 6 to 1,828 mL. The mean dose was 240 Gy for glass and 122 Gy for resin in TVs and 72 Gy for glass and 47 Gy for resin in NTVs. was 1.46 ± 0.58 (0.65–2.53) for glass and 1.16 ± 0.41 (0.54–2.54) for resin, and the respective values for were 0.88 ± 0.15 (0.56–1.00) and 0.86 ± 0.2 (0.58–1.35). DR variability was substantially lower in NTVs than in TVs. The Lin concordance between and (resin) was significantly better for tumors larger than 150 mL than for tumors 150 mL or smaller ( = 0.93 and = 0.95 vs. = 0.57 and = 0.93; P < 0.05). Conclusion: In 90Y radioembolization of HCC, predictive dosimetry based on 99mTc-MAA SPECT/CT provided good estimates of absorbed doses calculated from posttreatment 90Y TOF PET/CT for tumor and nontumor tissues. The low variability of demonstrates that pretreatment dosimetry is particularly suitable for minimizing radiation-induced hepatotoxicity.